Blog

Archives: May 2017

A Hamilton patient is the first trial participant to receive a novel experimental immunotherapy for lung cancer.

May 01, 2017   |   Blog

"Lung cancer is the most common kind of cancer in Canada, with more than 28,000 new diagnoses each year," said trial leader Dr. Rosalyn Juergens, oncologist at Hamilton Health Sciences and Associate Professor of Oncology at McMaster University.

Read More